(Q67750630)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1738379%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

title

Allopurinol in the treatment of American cutaneous leishmaniasis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1738379%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

Allopurinol in the Treatment of American Cutaneous Leishmaniasis (English)

1 reference

https://api.crossref.org/works/10.1056/NEJM199203123261105

mucocutaneous leishmaniasis

12 November 2022

main subject

cutaneous leishmaniasis

1 reference

1 reference

1 reference

S. Martinez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1738379

12 November 2022

J. J. Marr

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1738379

12 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1738379

12 November 2022

publication date

1 March 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1738379%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

12 March 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1738379

full work available at URL

12 November 2022

http://www.nejm.org/doi/pdf/10.1056/NEJM199203123261105

1 reference

https://api.crossref.org/works/10.1056/NEJM199203123261105

The New England Journal of Medicine

12 November 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1738379%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

volume

326

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1738379%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

page(s)

741-744

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1738379%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1738379%20AND%20SRC:MED&resulttype=core&format=json

Purine metabolism in Leishmania donovani amastigotes and promastigotes

17 September 2019

cites work

2

1 reference

https://api.crossref.org/works/10.1056/NEJM199203123261105

Pyrazolopyrimidine metabolism in the pathogenic trypanosomatidae

12 November 2022

3

1 reference

https://api.crossref.org/works/10.1056/NEJM199203123261105

Antileishmanial effect of allopurinol and allopurinol ribonucleoside on intracellular forms of Leishmania donovani

12 November 2022

4

1 reference

https://api.crossref.org/works/10.1056/NEJM199203123261105

Antileishmanial action of 4-thiopyrazolo (3.4-d) pyrimidine and its ribonucleoside. Biological effects and metabolism

12 November 2022

5

1 reference

https://api.crossref.org/works/10.1056/NEJM199203123261105

The synergistic action of pyrazolopyrimidines and pentavalent antimony against Leishmania donovani and L. braziliensis

12 November 2022

7

1 reference

https://api.crossref.org/works/10.1056/NEJM199203123261105

Evaluation of allopurinol in the treatment of kala-azar occurring in North Bihar, India

12 November 2022

8

1 reference

https://api.crossref.org/works/10.1056/NEJM199203123261105

Allopurinol in the treatment of visceral leishmaniasis

12 November 2022

9

1 reference

https://api.crossref.org/works/10.1056/NEJM199203123261105

Visceral leishmaniasis unresponsive to antimonial drugs. III. Successful treatment using a combination of sodium stibogluconate plus allopurinol.

12 November 2022

10

1 reference

https://api.crossref.org/works/10.1056/NEJM199203123261105

Treatment of American cutaneous leishmaniasis with orally administered allopurinol riboside

12 November 2022

11

1 reference

https://api.crossref.org/works/10.1056/NEJM199203123261105

Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy, and future strategies

12 November 2022

12

1 reference

https://api.crossref.org/works/10.1056/NEJM199203123261105

12 November 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1738379%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference